SCHEMBL13523213

SCHEMBL13523213

Cc1cc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(C)c34)cc2)ccc1F

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 20/20 0.81
FLT3 P36888 17/20 0.81
KIT P10721 14/20 0.81
FLT4 P35916 10/20 0.81
CSF1R P07333 9/20 0.81
FLT1 P17948 8/20 0.81
LYN P07948 7/20 0.81
LCK P06239 7/20 0.81
SRC P12931 6/20 0.81
BLK P51451 6/20 0.81
FYN P06241 4/20 0.81
CDK19 Q9BWU1 3/20 0.81
PLK4 O00444 5/20 0.63
AURKA O14965 5/20 0.63
ROCK2 O75116 5/20 0.63
PRKACA P17612 5/20 0.63
RPS6KB1 P23443 5/20 0.63
CSNK1D P48730 5/20 0.63
STK3 Q13188 5/20 0.63
ROCK1 Q13464 5/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL423038 0.90 KDR (1.00) KDRFLT3KITFLT4CSF1R
SCHEMBL421458 0.81 KDR (1.00) KDRFLT3KITFLT4CSF1R
SCHEMBL13523211 0.80 KDR (0.80) KDRFLT3KITFLT4CSF1R
SCHEMBL419459 0.79 KDR (1.00) KDRFLT3KITFLT4CSF1R
SCHEMBL419765 0.77 KDR (1.00) KDRFLT3KITFLT4CSF1R
Linifanib SCHEMBL93804 0.77 KDR (1.00) KDRFLT3KITFLT4CSF1R
SCHEMBL6073436 0.77 KDR (0.79) KDRFLT3KITFLT4CSF1R
Linifanib SCHEMBL29375368 0.77 KDR (1.00) KDRFLT3KITFLT4CSF1R
SCHEMBL13523217 0.77 KDR (0.80) KDRFLT3KITFLT4CSF1R
SCHEMBL424333 0.77 KDR (1.00) KDRFLT3KITFLT4CSF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100004306-A1 PIGF-1 Assay and kits and components thereof ABBOTT LABORATORIES (US) 2010-01-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004306-A1 PIGF-1 Assay and kits and components thereof PGF, FLT1, HDGF KDR 9/4885FLT3 773/4885KIT 140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.